Chongqing Aiyong Xingchen Standard Pharmaceutical Service Technology Co., Ltd.

Chongqing Aiyong Xingchen Supply Chain Management Co., Ltd. (AI & Shen) focuses on outsourcing services for the pharmaceutical industry chain. Centering on domestic and international pharmaceutical industrial (pharmaceutical factory) clients, the company leverages service networks covering marketing, academia, business, and headquarters parks across the country, and uses information technologies such as the Internet and big data to serve segments including pharmaceutical CSO, CRO, supply chain, hospitals, doctors, and medication users, providing enterprises with compliance consulting, CSO and CSO system organizational management, CRO, registration, and settlement services, and is committed to becoming a leader in industry service standards. Since 2016, in response to new enterprise needs arising from industry transformation and upgrading and market restructuring in the pharmaceutical industry, the company has innovated and implemented three major service systems: (1) Pharmaceutical industrial enterprise service system: marketing service supply chain control solution consulting, sales outsourcing services (CSO), contract research and scientific research empowerment (CRO) services, and procurement collaboration solutions and services. (2) Pharmaceutical commercial enterprise service system (CSOS): academic promotion services, sales promotion services, and organizational management services. (3) Policy compliance and risk control service system: financial and tax planning services, legal and compliance services, and park and settlement services. In 2019, the company established eight major service departments under a group governance structure: Commerce Department, Operations Center (CSOS Operations Center, Park Service Center), Finance Center, Legal Department, Product and Planning Development Department, CSO Marketing Center, Data and Information Center, CRO Research Institute, and other institutions, among which there are 6 independent subsidiaries. At present, it has served 8 large pharmaceutical factories and pharmaceutical commercial companies.